BeOne Medicines AG Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	286.93	-644.79	-881.71	-2,004	-1,458
Depreciation & Amortization	-	167.03	83.94	63.05	45.49
Other Amortization	-	4.73	3.74	3.23	0.97
Asset Writedown & Restructuring Costs	-	-13.23	-8.49	-27.74	-28.99
Loss (Gain) From Sale of Investments	-	24.02	16.22	22	-7.63
Stock-Based Compensation	-	441.62	367.62	303.16	240.71
Other Operating Activities	840.65	37.15	-368.23	11.11	26.89
Change in Accounts Receivable	-	-329.44	-188.31	304.11	-423.02
Change in Inventory	-	-91.5	-140.95	-56.69	-153.33
Change in Accounts Payable	-	121.5	21.48	-4.35	20.01
Change in Unearned Revenue	-	0.63	-255.59	-151.82	407.7
Change in Other Net Operating Assets	-	141.64	192.82	41.14	30.3
Operating Cash Flow	1,128	-140.63	-1,157	-1,497	-1,299
Capital Expenditures	-	-492.66	-561.9	-325.43	-262.94
Sale (Purchase) of Intangibles	-	-36.47	-34.37	-143.67	-51.91
Investment in Securities	-	-16.35	658.34	1,548	955.51
Other Investing Activities	-276.16	-2.86	-2.08	-1.49	-
Investing Cash Flow	-276.16	-548.35	60	1,077	640.66
Short-Term Debt Issued	-	868.27	661.53	313.77	406.45
Long-Term Debt Issued	-	9.05	22.5	37.37	16.84
Total Debt Issued	-	877.32	684.03	351.15	423.29
Short-Term Debt Repaid	-	-704.22	-309.58	-417.08	-321.75
Long-Term Debt Repaid	-	-28.03	-13.69	-	-
Total Debt Repaid	-	-732.25	-323.27	-417.08	-321.75
Net Debt Issued (Repaid)	-	145.08	360.77	-65.94	101.53
Issuance of Common Stock	-	45.37	55.71	46.96	3,535
Other Financing Activities	1,059	3	-	-	-
Financing Cash Flow	1,059	193.45	416.48	-18.97	3,637
Foreign Exchange Rate Adjustments	60.02	-51.71	-8.08	-69.38	14.04
Net Cash Flow	1,971	-547.24	-689.05	-507.85	2,993
Free Cash Flow	1,128	-633.29	-1,719	-1,822	-1,562
Free Cash Flow Margin	21.10%	-16.62%	-69.93%	-128.68%	-132.76%
Free Cash Flow Per Share	9.94	-6.01	-16.47	-17.67	-16.83
Cash Interest Paid	-	51.18	19.75	25.17	29.97
Cash Income Tax Paid	-	69.43	56	29.5	15.7
Levered Free Cash Flow	950.89	-367	-1,274	-943.69	-1,204
Unlevered Free Cash Flow	987.29	-357.79	-1,271	-931.75	-1,186
Change in Working Capital	-	-157.17	-370.54	132.39	-118.35

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.